Helpful links and resources for primary biliary cholangitis (PBC)
There are many associations and organizations that offer support for people living with PBC and provide information about ongoing research in the field.
There are many associations and organizations that offer support for people living with PBC and provide information about ongoing research in the field.
There are a number of experimental treatments in late-stage clinical trials to potentially become new treatments for primary biliary cholangitis (PBC).
We’ve provided the answers to some of the most frequently asked questions related to PBC.
Though there is no known cure for primary biliary cholangitis (PBC), several therapeutic options are available.
There is currently no cure for primary biliary cholangitis (PBC), but there are some options available for patients to delay progression.
The prognosis of primary biliary cholangitis (PBC) varies by patient, but the average time it takes for PBC to progress to the terminal stage is around 15 to 20 years.
The signs and symptoms of primary biliary cholangitis (PBC) vary and may not always correlate with the severity of the damage to the liver.
Primary biliary cholangitis (PBC) is a rare disease, and some patients may not present with any symptoms at all.
The exact cause of primary biliary cholangitis is not known, but there are some risk factors associated with the disease.
Primary biliary cholangitis (PBC) is an autoimmune disease in which the body’s immune system mistakenly attacks the bile ducts in the liver.